The risk or severity of adverse effects can be increased when bromocriptine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when efavirenz is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Tixocortol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Eprosartan.


The risk or severity of adverse effects can be increased when pirenzepine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when tolterodine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when duloxetine is combined with pimozide.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when oxymorphone is combined with theobromine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Etidocaine.


The risk or severity of adverse effects can be increased when olanzapine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when acebutolol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when clozapine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when labetalol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when levorphanol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when butalbital is combined with clomipramine.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with sulpiride.


The risk or severity of adverse effects can be increased when lorazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when Voriconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DESONIDE is combined with decamethonium.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with amisulpride.


The risk or severity of adverse effects can be increased when Isometheptene is combined with prilocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with pargyline.


The risk or severity of adverse effects can be increased when levorphanol is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when levorphanol is combined with thiothixene.


The risk or severity of adverse effects can be increased when Masoprocol is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when hexetidine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when nicardipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with spironolactone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when nicardipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when etizolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when losartan is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when paroxetine is combined with Dothiepin.


The risk or severity of adverse effects can be increased when methysergide is combined with clofazimine.


The risk or severity of adverse effects can be increased when triazolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with flumethasone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with suprofen.


The risk or severity of adverse effects can be increased when cocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when prazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when prazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when amoxapine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Spirapril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when diclofenac is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when scopolamine is combined with quinidine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with DESONIDE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with lidocaine.


The risk or severity of adverse effects can be increased when pramipexole is combined with papaverine.


The risk or severity of adverse effects can be increased when pramipexole is combined with nifedipine.


The risk or severity of adverse effects can be increased when proparacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with bumetanide.


The risk or severity of adverse effects can be increased when scopolamine is combined with zonisamide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with quinapril.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when triamterene is combined with propranolol.


The risk or severity of adverse effects can be increased when triamterene is combined with clonidine.


The risk or severity of adverse effects can be increased when metolazone is combined with clonidine.


The risk or severity of adverse effects can be increased when metolazone is combined with propranolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with efavirenz.


The risk or severity of adverse effects can be increased when risperidone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with diflorasone.


The risk or severity of adverse effects can be increased when trandolapril is combined with carprofen.


The risk or severity of adverse effects can be increased when benzphetamine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with tetracycline.


The risk or severity of adverse effects can be increased when codeine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with ambenonium.


The risk or severity of adverse effects can be increased when azelastine is combined with budesonide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with acebutolol.


The risk or severity of adverse effects can be increased when naratriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when buspirone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when benztropine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when argatroban is combined with meperidine.


The risk or severity of adverse effects can be increased when bepridil is combined with D-mannitol.


The risk or severity of adverse effects can be increased when ropinirole is combined with metolazone.


The risk or severity of adverse effects can be increased when ethanol is combined with bromocriptine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with halothane.


The risk or severity of adverse effects can be increased when Tramadol is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Perospirone.


The risk or severity of adverse effects can be increased when DESONIDE is combined with galanthamine.


The risk or severity of adverse effects can be increased when Etomidate is combined with promethazine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with antipyrine.


The risk or severity of adverse effects can be increased when trazodone is combined with Eletriptan.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Etomidate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when labetalol is combined with methyldopa.


The risk or severity of adverse effects can be increased when labetalol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Normethadone.


The risk or severity of adverse effects can be increased when labetalol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with moclobemide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with scopolamine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when amobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cabergoline is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when triamterene is combined with nimodipine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when valsartan is combined with propranolol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when valsartan is combined with clonidine.


The risk or severity of adverse effects can be increased when betaxolol is combined with furosemide.


The risk or severity of adverse effects can be increased when propofol is combined with carvedilol.


The risk or severity of adverse effects can be increased when betaxolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when procarbazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when methscopolamine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Vilazodone is combined with trimipramine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when clozapine is combined with prilocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with CYPROTERONE ACETATE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with bumetanide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when clomipramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when rasagiline is combined with MELPERONE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with enoxacin.


The risk or severity of adverse effects can be increased when Benidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when procarbazine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Ephedrine is combined with celiprolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when timolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Thioproperazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when medrysone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Triflusal.


The risk or severity of adverse effects can be increased when Nabilone is combined with losartan.


The risk or severity of adverse effects can be increased when Efonidipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when valsartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Nabilone.


The risk or severity of adverse effects can be increased when Salsalate is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with pargyline.


The risk or severity of adverse effects can be increased when Lacidipine is combined with sotalol.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Tapentadol.


The risk or severity of adverse effects can be increased when clemastine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with periciazine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with hydromorphone.


The risk or severity of adverse effects can be increased when diflunisal is combined with Ditazole.


The risk or severity of adverse effects can be increased when propofol is combined with bumetanide.


The risk or severity of adverse effects can be increased when Vilazodone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when propofol is combined with quinapril.


The risk or severity of adverse effects can be increased when diflunisal is combined with epirizole.


The risk or severity of adverse effects can be increased when MELPERONE is combined with desipramine.


The risk or severity of adverse effects can be increased when xylometazoline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with flunarizine.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with Carbetocin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when oxycodone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when diclofenac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Naftifine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when zaleplon is combined with trazodone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with quetiapine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clomipramine is combined with celiprolol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with zonisamide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with tiagabine.


The risk or severity of adverse effects can be increased when Artemether is combined with Amrinone.


The risk or severity of adverse effects can be increased when prilocaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when nimesulide is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with adenosine.


The risk or severity of adverse effects can be increased when naratriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Imatinib is combined with sulpiride.


The risk or severity of adverse effects can be increased when naratriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when primidone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when trimipramine is combined with meclizine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with budesonide.


The risk or severity of adverse effects can be increased when topiramate is combined with levodopa.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Pentolinium.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Normethadone is combined with primidone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with spironolactone.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with decamethonium.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with triprolidine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when clonidine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when enflurane is combined with tetracaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when bromazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when temazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Milnacipran.


The risk or severity of adverse effects can be increased when maprotiline is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with equilin.


The risk or severity of adverse effects can be increased when valsartan is combined with reserpine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when loxapine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when loxapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Normethadone is combined with butalbital.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when trazodone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when sulindac is combined with medrysone.


The risk or severity of adverse effects can be increased when Icatibant is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when diltiazem is combined with sotalol.


The risk or severity of adverse effects can be increased when trandolapril is combined with meperidine.


The risk or severity of adverse effects can be increased when secobarbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when spironolactone is combined with terazosin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with medrysone.


The risk or severity of adverse effects can be increased when leflunomide is combined with alclofenac.


The risk or severity of adverse effects can be increased when pentazocine is combined with triprolidine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when pentazocine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when pentazocine is combined with spironolactone.


The risk or severity of adverse effects can be increased when salicylamide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when pergolide is combined with glyburide.


The risk or severity of adverse effects can be increased when Eprosartan is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with clemastine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with lidocaine.


The risk or severity of adverse effects can be increased when Droxicam is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when moclobemide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when trimipramine is combined with dobutamine.


The risk or severity of adverse effects can be increased when butabarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when floctafenine is combined with halcinonide.


The risk or severity of adverse effects can be increased when ketamine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when floctafenine is combined with difluprednate.


The risk or severity of adverse effects can be increased when ondansetron is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Apremilast is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ketamine is combined with thiopental.


The risk or severity of adverse effects can be increased when glutethimide is combined with meclizine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with procarbazine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with desipramine.


The risk or severity of adverse effects can be increased when metoprolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when butalbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with formestane.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Escitalopram.


The risk or severity of adverse effects can be increased when amitriptyline is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when amitriptyline is combined with moclobemide.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Lofexidine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when amisulpride is combined with fexofenadine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with azelastine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Melatonin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Agomelatine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when promazine is combined with pimozide.


The risk or severity of adverse effects can be increased when Halazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when doxepin is combined with isoetharine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with felbamate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when ketamine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when temazepam is combined with flurazepam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with aspirin.


The risk or severity of adverse effects can be increased when minoxidil is combined with captopril.


The risk or severity of adverse effects can be increased when benzocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when risperidone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when temazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with meperidine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Masoprocol is combined with etodolac.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when bifonazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with betamethasone.


The risk or severity of adverse effects can be increased when fosinopril is combined with hydralazine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulpiride is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when floctafenine is combined with Olsalazine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when mesalamine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when methadone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Demecarium.


The risk or severity of adverse effects can be increased when pentamidine is combined with eperisone.


The risk or severity of adverse effects can be increased when amobarbital is combined with flunarizine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when amobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when amobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when methadone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with fluvastatin.


The risk or severity of adverse effects can be increased when methadone is combined with lithium ion.


The risk or severity of adverse effects can be increased when methadone is combined with amobarbital.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when Bretylium is combined with hydralazine.


The risk or severity of adverse effects can be increased when Ecabet is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with loxapine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when selegiline is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Eprosartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with rasagiline.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when quinapril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when thiopental is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when triazolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when triazolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with HEROIN.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Bortezomib is combined with hydralazine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when fluoxetine is combined with amoxapine.


The risk or severity of adverse effects can be increased when diazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when diazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when diazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when propofol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Salsalate is combined with estrone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when ramipril is combined with ketorolac.


The risk or severity of adverse effects can be increased when propofol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Apixaban is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when trimipramine is combined with flunarizine.


The risk or severity of adverse effects can be increased when celecoxib is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when trimipramine is combined with celiprolol.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with zotepine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with sertraline.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with amitriptyline.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with nilutamide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Tolcapone.


The risk or severity of adverse effects can be increased when nifedipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Butethal is combined with zotepine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when mesalamine is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when ropinirole is combined with quinapril.


The risk or severity of adverse effects can be increased when ropinirole is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when brotizolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when barnidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when desipramine is combined with celiprolol.


The risk or severity of adverse effects can be increased when reserpine is combined with benazepril.


The risk or severity of adverse effects can be increased when manidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when reserpine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when estazolam is combined with brotizolam.


The risk or severity of adverse effects can be increased when metaraminol is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when amcinonide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when amcinonide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with felodipine.


The risk or severity of adverse effects can be increased when nicergoline is combined with raloxifene.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Normethadone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Salsalate is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with moclobemide.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with butalbital.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when triamcinolone is combined with decamethonium.


The risk or severity of adverse effects can be increased when tretinoin is combined with propranolol.


The risk or severity of adverse effects can be increased when nabumetone is combined with Mometasone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with brotizolam.


The risk or severity of adverse effects can be increased when protriptyline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with terazosin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when methadone is combined with zonisamide.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with malathion.


The risk or severity of adverse effects can be increased when barnidipine is combined with papaverine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with leflunomide.


The risk or severity of adverse effects can be increased when piracetam is combined with L-thyroxine.


The risk or severity of adverse effects can be increased when tiagabine is combined with doxepin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when pentazocine is combined with levorphanol.


The risk or severity of adverse effects can be increased when alprazolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when pentazocine is combined with perphenazine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with primidone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with prednisone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nicergoline is combined with Pazopanib.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when linezolid is combined with amisulpride.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with moclobemide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with oxaprozin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with paramethasone.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with topiramate.


The risk or severity of adverse effects can be increased when biperiden is combined with oxybutynin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when alprazolam is combined with buspirone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when perphenazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when isradipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when alprazolam is combined with oxycodone.


The risk or severity of adverse effects can be increased when fenbufen is combined with acemetacin.


The risk or severity of adverse effects can be increased when metolazone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when perphenazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when halothane is combined with loratadine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nicardipine.


The risk or severity of adverse effects can be increased when halothane is combined with prazosin.


The risk or severity of adverse effects can be increased when clozapine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with tizanidine.


The risk or severity of adverse effects can be increased when levorphanol is combined with proparacaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with benzthiazide.


The risk or severity of adverse effects can be increased when levorphanol is combined with Halazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with flurazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when levorphanol is combined with indapamide.


The risk or severity of adverse effects can be increased when clorazepate is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when methyldopa is combined with quetiapine.


The risk or severity of adverse effects can be increased when argatroban is combined with aspirin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when zopiclone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when benzocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with betaxolol.


The risk or severity of adverse effects can be increased when dienestrol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when estrone is combined with ambenonium.


The risk or severity of adverse effects can be increased when ibudilast is combined with mesalamine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when teniposide is combined with leflunomide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with budesonide.


The risk or severity of adverse effects can be increased when trazodone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with quetiapine.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when estrone is combined with physostigmine.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with duloxetine.


The risk or severity of adverse effects can be increased when thiotepa is combined with leflunomide.


The risk or severity of adverse effects can be increased when valsartan is combined with enalapril.


The risk or severity of adverse effects can be increased when triflupromazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with gabapentin.


The risk or severity of adverse effects can be increased when reserpine is combined with tiapride.


The risk or severity of adverse effects can be increased when lorazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with resveratrol.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when atenolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Pramocaine.


The risk or severity of adverse effects can be increased when enalapril is combined with alclofenac.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when sulindac is combined with carprofen.


The risk or severity of adverse effects can be increased when Olmesartan is combined with oxaprozin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with tiapride.


The risk or severity of adverse effects can be increased when hexetidine is combined with felodipine.


The risk or severity of adverse effects can be increased when epinephrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with trimipramine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when gabapentin is combined with procaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with meclizine.


The risk or severity of adverse effects can be increased when timolol is combined with nadolol.


The risk or severity of adverse effects can be increased when metoclopramide is combined with paroxetine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with bumetanide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with thalidomide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with phenytoin.


The risk or severity of adverse effects can be increased when lorazepam is combined with carbamazepine.


The risk or severity of adverse effects can be increased when methadone is combined with Etomidate.


The risk or severity of adverse effects can be increased when carprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when cabergoline is combined with risperidone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when carprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with equilin.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with pentazocine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when carprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with anastrozole.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with butamben.


The risk or severity of adverse effects can be increased when cetirizine is combined with primidone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with spironolactone.


The risk or severity of adverse effects can be increased when zonisamide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when furosemide is combined with Spectinomycin.


The risk or severity of adverse effects can be increased when benzocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with etizolam.


The risk or severity of adverse effects can be increased when Asenapine is combined with loratadine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Linagliptin is combined with trandolapril.


The risk or severity of adverse effects can be increased when rizatriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when naloxone is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when rizatriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when triamterene is combined with indapamide.


The risk or severity of adverse effects can be increased when selegiline is combined with linezolid.


The risk or severity of adverse effects can be increased when diflunisal is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nitrendipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when metolazone is combined with lisinopril.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when estazolam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nitrazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when Lurasidone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when lisinopril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when nicergoline is combined with nicotinamide.


The risk or severity of adverse effects can be increased when metolazone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with anagrelide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with carmustine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with flunisolide.


The risk or severity of adverse effects can be increased when triprolidine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when olanzapine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Miltefosine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nisoldipine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when trazodone is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with trimipramine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when butorphanol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when tetracaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when amcinonide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Perospirone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Perospirone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with resveratrol.


The risk or severity of adverse effects can be increased when reserpine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Flupentixol is combined with gabapentin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with gabapentin.


The risk or severity of adverse effects can be increased when aspirin is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Tianeptine is combined with procarbazine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Erismodegib.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with losartan.


The risk or severity of adverse effects can be increased when fosinopril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with sulindac.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with chloroquine.


The risk or severity of adverse effects can be increased when benztropine is combined with Propiverine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when nortriptyline is combined with rasagiline.


The risk or severity of adverse effects can be increased when procarbazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with tubocurarine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Eplerenone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Isometheptene.


The risk or severity of adverse effects can be increased when tolazamide is combined with ethanol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with papaverine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with testosterone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nicardipine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when oxiconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when zonisamide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when triprolidine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with celecoxib.


The risk or severity of adverse effects can be increased when ramipril is combined with indapamide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with thioridazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with losartan.


The risk or severity of adverse effects can be increased when cocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when dobutamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Melatonin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with promethazine.


The risk or severity of adverse effects can be increased when dobutamine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with sotalol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Tadalafil.


The risk or severity of adverse effects can be increased when tolterodine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when tropicamide is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with dyclonine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with diazepam.


The risk or severity of adverse effects can be increased when clotrimazole is combined with bepridil.


The risk or severity of adverse effects can be increased when Pipamperone is combined with trandolapril.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with thioridazine.


The risk or severity of adverse effects can be increased when tropicamide is combined with oxybutynin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when hydromorphone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when proparacaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when indapamide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when sulindac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when rasagiline is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when thiamylal is combined with scopolamine.


The risk or severity of adverse effects can be increased when perphenazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with oxybutynin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tolazoline.


The risk or severity of adverse effects can be increased when bromocriptine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when trazodone is combined with duloxetine.


The risk or severity of adverse effects can be increased when thalidomide is combined with timolol.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when alprazolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when salicylamide is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with meclizine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with triamterene.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when olanzapine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when butalbital is combined with amitriptyline.


The risk or severity of adverse effects can be increased when olanzapine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Riociguat.


The risk or severity of adverse effects can be increased when nabumetone is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when sulindac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when ATROPINE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ketamine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with morphine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with quetiapine.


The risk or severity of adverse effects can be increased when clonidine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when secobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when tetracaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when loteprednol is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when ketamine is combined with dantrolene.


The risk or severity of adverse effects can be increased when prilocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when prilocaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Sacubitril is combined with diclofenac.


The risk or severity of adverse effects can be increased when lisinopril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when losartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when clomipramine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when clomipramine is combined with rasagiline.


The risk or severity of adverse effects can be increased when nimesulide is combined with halcinonide.


The risk or severity of adverse effects can be increased when midazolam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when nimesulide is combined with difluprednate.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with sertraline.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with phenytoin.


The risk or severity of adverse effects can be increased when Talniflumate is combined with azelastine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when zaleplon is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when docetaxel is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when perphenazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when risperidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nimodipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when sotalol is combined with hydralazine.


The risk or severity of adverse effects can be increased when sotalol is combined with Varenicline.


The risk or severity of adverse effects can be increased when butenafine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when perphenazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiamylal is combined with Iloperidone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with maprotiline.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with nefazodone.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with citalopram.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when loxapine is combined with promazine.


The risk or severity of adverse effects can be increased when loxapine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when loxapine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when loxapine is combined with triprolidine.


The risk or severity of adverse effects can be increased when flurazepam is combined with lidocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when lisinopril is combined with diclofenac.


The risk or severity of adverse effects can be increased when bromocriptine is combined with thalidomide.


The risk or severity of adverse effects can be increased when Paliperidone is combined with lidocaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with clemastine.


The risk or severity of adverse effects can be increased when tiapride is combined with ethosuximide.


The risk or severity of adverse effects can be increased when trandolapril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with levorphanol.


The risk or severity of adverse effects can be increased when butorphanol is combined with Articaine.


The risk or severity of adverse effects can be increased when trimethoprim is combined with memantine.


The risk or severity of adverse effects can be increased when Etomidate is combined with topiramate.


The risk or severity of adverse effects can be increased when Eletriptan is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when estazolam is combined with quetiapine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when benzocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when temazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when metolazone is combined with quinapril.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with fluoxetine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with duloxetine.


The risk or severity of adverse effects can be increased when propofol is combined with Retigabine.


The risk or severity of adverse effects can be increased when metolazone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when moclobemide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with memantine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Paliperidone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with prilocaine.


The risk or severity of adverse effects can be increased when chlorpropamide is combined with ethanol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with ethotoin.


The risk or severity of adverse effects can be increased when promazine is combined with quazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when proparacaine is combined with citalopram.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with hydralazine.


The risk or severity of adverse effects can be increased when butalbital is combined with protriptyline.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when ramipril is combined with carvedilol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with epirizole.


The risk or severity of adverse effects can be increased when Sacubitril is combined with indapamide.


The risk or severity of adverse effects can be increased when propofol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Mersalyl.


The risk or severity of adverse effects can be increased when propofol is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when propofol is combined with baclofen.


The risk or severity of adverse effects can be increased when diazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when formestane is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with flumethasone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when clomipramine is combined with propranolol.


The risk or severity of adverse effects can be increased when oxycodone is combined with zopiclone.


The risk or severity of adverse effects can be increased when procyclidine is combined with levorphanol.


The risk or severity of adverse effects can be increased when oxycodone is combined with oxymorphone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Olmesartan is combined with salicylic acid.


The risk or severity of adverse effects can be increased when nimesulide is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with HEROIN.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ondansetron is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when bromazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when ethosuximide is combined with doxepin.


The risk or severity of adverse effects can be increased when bromazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nitrendipine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when timolol is combined with indapamide.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Asenapine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Halobetasol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when propofol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when propofol is combined with prazepam.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when apomorphine is combined with bupropion.


The risk or severity of adverse effects can be increased when hydromorphone is combined with propofol.


The risk or severity of adverse effects can be increased when chloroquine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when ropinirole is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when apomorphine is combined with Bretylium.


The risk or severity of adverse effects can be increased when hydromorphone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when irbesartan is combined with captopril.


The risk or severity of adverse effects can be increased when Efonidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when equilin is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when irbesartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with levorphanol.


The risk or severity of adverse effects can be increased when apomorphine is combined with reserpine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with D-mannitol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with etizolam.


The risk or severity of adverse effects can be increased when glutethimide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with dantrolene.


The risk or severity of adverse effects can be increased when minoxidil is combined with cilazapril.


The risk or severity of adverse effects can be increased when meclizine is combined with zonisamide.


The risk or severity of adverse effects can be increased when metolazone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with tiagabine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when quetiapine is combined with meclizine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with clidinium.


The risk or severity of adverse effects can be increased when MELPERONE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when rapamycin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when cetirizine is combined with efavirenz.


The risk or severity of adverse effects can be increased when sertraline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with butalbital.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when prilocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Romidepsin.


The risk or severity of adverse effects can be increased when rizatriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with primidone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with moclobemide.


The risk or severity of adverse effects can be increased when nelfinavir is combined with toremifene.


The risk or severity of adverse effects can be increased when dibucaine is combined with primidone.


The risk or severity of adverse effects can be increased when quetiapine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxycodone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when nelfinavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when resveratrol is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Metixene is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when diclofenac is combined with Masoprocol.


The risk or severity of adverse effects can be increased when meperidine is combined with amoxapine.


The risk or severity of adverse effects can be increased when dopamine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Rivaroxaban is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when pancuronium is combined with Propiverine.


The risk or severity of adverse effects can be increased when brotizolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with loratadine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with meperidine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with droperidol.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when dibucaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when metoprolol is combined with indapamide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with imipramine.


The risk or severity of adverse effects can be increased when dibucaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when rivastigmine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when benzocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when quazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when bromazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when cabergoline is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with furosemide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when morphine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when meperidine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when bupivacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when trandolapril is combined with Naftifine.


The risk or severity of adverse effects can be increased when Halazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when butamben is combined with clonidine.


The risk or severity of adverse effects can be increased when haloperidol is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when pimozide is combined with quetiapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Etomidate.


The risk or severity of adverse effects can be increased when diltiazem is combined with triamterene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with bupivacaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with Butethal.


The risk or severity of adverse effects can be increased when floctafenine is combined with Naftifine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with felbamate.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Salsalate.


The risk or severity of adverse effects can be increased when pimozide is combined with Asenapine.


The risk or severity of adverse effects can be increased when meperidine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dihydrotachysterol is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when indapamide is combined with ouabain.


The risk or severity of adverse effects can be increased when meprobamate is combined with cocaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with triamterene.


The risk or severity of adverse effects can be increased when benazepril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with terazosin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Cangrelor is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when benzocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methadone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when dipyridamole is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when prazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when Telmisartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when trimipramine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when trimipramine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with meclizine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with fosinopril.